Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro
Article in Toxicology (August 2021)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Toxicology (August 2021)
Article in Nutrients (April 2021)
Article in Pharmacological Research (December 2020)